“Never doubt that a small group of thoughtful, committed citizens can change the world: Indeed, it’s the only thing that ever has.”
— Margaret Mead
March 13, 2008, heralds the third annual World Kidney Day (WKD), an event that will be celebrated in more than 60 countries. We take this opportunity to recount how this concept has gained worldwide traction and momentum and to reflect on the challenges faced by its creators and supporters.
The Beginnings of WKD
There have probably been many individuals who conceived of marking one calendar day in which to call attention to the seriousness of kidney disease globally; many may even have shared their thoughts with others, but there is one individual who not only conceived the idea but was persistent in persuading many in leadership positions to bring this notion—a World Kidney Day—to fruition. This individual is also the founder of the International Federation of Kidney Foundations (IFKF): Joel Kopple. He first conceived the idea of WKD in the spring of 2003, recognizing that chronic kidney disease (CKD) is a global, public health threat but is typically low on government health agendas; that it can be detected with simple and inexpensive tests yet national detection programs are rare; and that, although it can be treated with existing, effective therapies, few people with CKD receive appropriate health care.
In September 2003, Kopple wrote to Warwick Prime, then President of the IFKF, and proposed an annual WKD. To make it truly an international collaborative effort, representatives of IFKF and the International Society of Nephrology (ISN) met in November 2003, and at that meeting, Kopple presented a précis entitled “Proposal for the Establishment of a World Kidney Day.” A WKD ISN-IFKF liaison committee was established, with the initial membership consisting of William Couser, John Dirks, Joel Kopple, Warwick Prime, and Jan Weening. In 2004, both the IFKF Executive Committee and the ISN Council endorsed the WKD program, and the ISN agreed in 2005 to commit sufficient resources to enable a first WKD to be held on March 7, 2006. An editorial about WKD was published that month in eight scientific journals. Despite being planned with short notice and few resources, kidney organizations in 45 countries enthusiastically embraced the first WKD and organized health screening events, road shows, walkathons, public lectures, and press conferences. It was clear that WKD was responding to an urgent need and tapping the tremendous energy and motivation of kidney health professionals and patients and their friends and relatives across the globe.

Dr. Joel Kopple
That success was recognized by those from the ISN and the IFKF, who met in April 2006 and agreed on a formal organizational structure for WKD. A memorandum of understanding between the IFKF and the ISN for the planning and implementation of an annual WKD was signed in June 2006 by the two presidents, William Couser (ISN) and Sudhir Shah (IFKF). The document stated, “Based on a proposal and invitation by IFKF, IFKF and ISN jointly agree to declare an annual World Kidney Day to increase awareness, detection, prevention, and treatment of kidney and related diseases.” The “World Kidney Day” name and logo were trademarked and are now jointly owned by IFKF and ISN.
A WKD steering committee was established with eight members: Four members nominated by each organization, as well as a scientific advisory committee. The ISN agreed to provide the initial funding necessary for the central operational management of a WKD project team. The continued leadership of the ISN/IFKF Steering Committee in 2007 helped secure funding from global sponsors; create a WKD logo, slogan, web site and “brand”; widely disseminate designs for posters, banners, T shirts, and other promotional materials that could be adapted for local use; gain the moral support of celebrities ranging from Tom Hanks to Jacques Rogge; and enlist the participation of 66 countries.
The remarkable initiative and ingenuity of kidney organizations on March 8, 2007, can be viewed at http://www.worldkidneyday.org. The WKD web site will feature planned activities for March 13, 2008, which promises to be an even greater event, with continued emphasis on the message that “kidney disease is common, harmful and treatable.”
Main Challenges and Aims of WKD
Public Awareness
WKD offers a crucial, visible opportunity to inform and educate health policy makers, people who are at highest risk for CKD, and the general public. One of our greatest challenges is general ignorance about the kidneys. Surveys made before the advent of WKD have shown that less than 5% of the general population knows where the kidneys are located and what they do. Therefore, the WKD 2008 international campaign theme—Amazing Kidneys!—stresses the positive message that kidneys are truly amazing. A focus for the general public is on simple facts about what kidneys do for us on a daily basis, for example, “Every day our kidneys filter and clean 200 L of blood.” Amazing kidney stories can also be used—stories about kidney patients, kidney organ donors, and health professionals who are exceptional in some way. WKD offers an increasingly visible opportunity to tailor public awareness messages to the media for widespread impact.
Importance of CKD
Although each country and region may adopt different priorities for WKD from year to year—choosing, for example, to promote living-donor kidney transplantation or to push for improvements in dialysis facilities—in many countries, it is the detection and management of CKD that will be the dominant kidney health issue. On WKD, we must aim to raise awareness about the heavy burden of CKD on human lives and health care budgets and put CKD on the agenda of governments and other institutions around the world that shape and reform health policy. It is an opportunity to launch high-profile, new initiatives that will have an impact on CKD and to seek the endorsement of agencies that can help to ensure such initiatives become embedded into routine health care.
Since the term CKD came into usage and its staging was defined (1), there has been a flurry of investigative activities and publications on its importance (2–6). Recently published studies have confirmed that CKD is a common disorder globally, with as many as 90% of those who have CKD remaining unidentified (7,8). That CKD is a major public health issue is now beyond dispute (9), and it is obvious that an issue of this magnitude cannot be addressed by volunteer organizations alone.
Two simple and inexpensive tests are available to detect CKD: Urine for protein and blood for serum creatinine and, hence, estimated GFR (eGFR). Despite this, the task of developing widespread detection and management programs for CKD that produce improved outcomes at a reasonable cost is formidable. It is unlikely that even developed countries have adequate financial and human resources for whole-population screening programs for CKD and, in any case, there is so far no evidence that these are cost-effective.
CKD Detection Programs
On the basis of current information, we recommend that all countries have targeted screening programs. Steps to establishing an effective program include the following:
Reporting of eGFR by all laboratories that measure serum creatinine
Measuring eGFR and proteinuria in those at the highest risk for CKD, including all those with diabetes, hypertension, coronary heart disease, and cerebrovascular disease, who constitute the majority of patients with CKD and with ESRD
Regularly measuring BP, eGFR, and proteinuria in those identified with CKD
Establishing targets for BP control in those with CKD and appropriate use of drugs that block the renin-angiotensin system
Agreeing on guidelines for identifying the minority of people with CKD who benefit from the specialist advice of a nephrologist as well as the routine care of a family physician
In the United Kingdom, for example, there has been encouraging progress in the past few years toward the establishment of such a program. The reporting of eGFR is now mandated in all UK clinical laboratories, and guidelines for the detection and management of CKD have been widely accepted (10). This progress has been made more straightforward by a government-directed and government-funded health care system, which allows several aspects of the program to be linked to reimbursement for family physicians, who are already obliged to maintain computerized listings of all those with diabetes, hypertension, and coronary heart disease. There will be much greater challenges in countries where health care is provided by multiple independent agencies or in the developing world, where resources that are available for health care are much less.
In advocating for these programs that are now proving successful and cost-effective, we favor small but sure-footed steps (5,11); we must be careful that screening tests identify patients with true disease, for whom intervention will make a critical difference by delaying or avoiding ESRD, or by modifying risk factors for cardiovascular disease, which is so closely linked with CKD. This may be particularly true in the elderly, who are those with the highest prevalence of CKD and in whom preventive therapy is less likely to improve survival or quality of life (5,12). In parallel, we must press for research programs to address the many unanswered questions about CKD, not least to understand better the factors that predict the minority of those with stage 3 CKD who progress to ESRD and to test the efficacy of our new health care strategies for CKD.
WKD Is Here to Stay
The momentum of WKD is ensured, and we anticipate that many more than the previous 66 countries will be reporting to us their initiatives and successes on March 13, 2008. The WKD Steering Committee and Project Team will continue to provide a toolkit of resources (available for downloading at http://www.worldkidneyday.org) for each WKD, including messages, logos, posters, and designs for other materials. The power of WKD is generated by local action, led by those who understand the specific kidney health issues in their countries and who use this day to showcase successful initiatives already taken and launch positive changes in health care systems and practices. For meaningful progress to be made, activities related to kidney disease are needed throughout the year. Our vision is that WKD serves as an annual energizing and unifying event through which health care providers, the general public, and the government bodies that make health care policy all unite to improve early detection programs and optimize medical care for those millions worldwide who can benefit from an improved awareness of CKD as a global health issue.
Disclosures
None.
Acknowledgments
World Kidney Day Steering Committee: William G. Couser (ISN), John Davis (IFKF), Joel Kopple (IFKF), Thomas Reiser (ISN), Miguel Riella (ISN), and Anne Wilson (IFKF).
World Kidney Day 2007 Scientific Advisory Board: Vittorio E. Andreucci, Italy; Rashad S. Barsoum, Egypt; Allan J. Collins, United States; David C.H. Harris, Australia; Bernardo Rodriguez Iturbe, Venezuela; Paul E. De Jong, Netherlands; Robert W. Schrier, United States; and Philip Kam Tao Li, China.
Footnotes
Published online ahead of print. Publication date available at www.cjasn.org.
References
- 1.NKF: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, stratification. Part IV: Definition and classification of stages of chronic kidney disease. Am J Kidney Dis 39: S46–S75, 2002 [PubMed] [Google Scholar]
- 2.Archibald G, Bartlett W, Brown A, Christie B, Elliott A, Griffith K, Pound S, Rappaport I, Robertson D, Semple Y, Slane P, Whitworth C, Williams B: UK Consensus Conference on Early Chronic Kidney Disease: 6 and 7 February 2007. Nephrol Dial Transplant 22: 2455–2457, 2007 [DOI] [PubMed] [Google Scholar]
- 3.Vassalotti JA, Lesley AS, Levey AS: Testing for chronic kidney disease: A position statement from the National Kidney Foundation. Am J Kidney Dis 50: 169–180, 2007 [DOI] [PubMed] [Google Scholar]
- 4.Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G: Chronic kidney disease as a global public health problem: Approaches and initiatives—A position statement from Kidney Disease: Improving Global Outcomes. Kidney Int 72: 247–259, 2007 [DOI] [PubMed] [Google Scholar]
- 5.Couser WG: Chronic kidney disease: The promise and the perils. J Am Soc Nephrol 18: 2803–2805, 2007 [DOI] [PubMed] [Google Scholar]
- 6.Himmelfarb J: Chronic kidney disease and the public health. JAMA 297: 2630–2633, 2007 [DOI] [PubMed] [Google Scholar]
- 7.Stevens PE, O’Donoghue DJ, de Lusignan S, Van Vlymen J, Klebe B, Middleton R, Hague N, New J, Farmer CK: Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 72: 92–99, 2007 [DOI] [PubMed] [Google Scholar]
- 8.Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH: Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16: 180–188, 2005 [DOI] [PubMed] [Google Scholar]
- 9.Schoolwerth AC, Engelgau MM, Hostetter TH, Rufo KH, Chianchiano D, McClellan WM, Warnock DG, Vinicor F: Chronic kidney disease: A public health problem that needs a public health action plan. Prev Chronic Dis 3: A57, 2006 [PMC free article] [PubMed] [Google Scholar]
- 10.Joint Specialty Committee on Renal Medicine of the Royal College of Physicians and Renal Association, and the Royal College of General Practitioners: Chronic Kidney Disease In Adults: UK Guidelines for Identification, Management and Referral, London, Royal College of Physicians, 2006. Available at: http://www.renal.org/CKDguide/cdk.html [DOI] [PubMed] [Google Scholar]
- 11.Kiberd B: The chronic kidney disease epidemic: Stepping back and looking forward. J Am Soc Nephrol 17: 2967–2973, 2006 [DOI] [PubMed] [Google Scholar]
- 12.Kallen AJ, Patel PR: In search of a rational approach to chronic kidney disease detection and management. Kidney Int 72: 3–5, 2007 [DOI] [PubMed] [Google Scholar]
